| SARs | Structure–activity relationships |
| RSV | Resveratrol |
| PTS | Pterostilbene |
| BBB | Blood–brain barrier |
| MRSA | Methicillin-resistant Staphylococcus aureus |
| MIC | Minimum inhibitory concentration |
| MBC | Minimum bactericidal concentration |
| EC50 | Exhibited median effective concentration |
| Xoo | Xanthomonas oryzae pv. oryzae |
| Xoc | Xanthomonas oryzae pv. oryzicola |
| EPSs | Extracellular polysaccharides |
| MAPK | Mitogen-activated protein kinase |
| AD | Atopic dermatitis |
| DNCB | Dinitrochlorobenzene |
| GLUT1 | Glucose transporter protein 1 |
| ROS | Reactive oxygen species |
| EAE | Experimental autoimmune encephalomyelitis |
| LPS | Lipopolysaccharide |
| HFD | High-fat diet |
| TNF-α | Tumor necrosis factor-α |
| IL-6 | Interleukin-6 |
| IL-1β | Interleukin-1β |
| NF-κB | Nuclear transcription factor-κB |
| COX-2 | Cyclooxygenase-2 |
| PA | Palmitic acid |
| CAT | Catalase |
| GPX1 | Glutathione peroxidase 1 |
| p-ERK1/2 | Phosphorylated extracellular signal-regulated kinase 1/2 |
| IR | Inhibition rate |
| NLRP3 | Nucleotide-binding oligomerization domain-like receptor protein 3 |
| IBD | Inflammatory Bowel Disease |
| HO-1 | Oxygenase-1 |
| AChE | Acetylcholinesterase |
| BChE | Butyrylcholinesterase |
| PC | Pancreatic cancer |
| VRE | Vancomycin-resistant Enterococcus faecium and E. faecalis |
| CYP1 | Cytochrome P450 1 |
| TCDD | Tetrachlorodibenzo-p-dioxin |
| LM | Listeria monocytogenes |
| HUVECs | Human umbilical vein endothelial cells |
| SI | Selectivity index |
| MCAO/R | Middle cerebral artery occlusion–reperfusion |
| OGD/R | Oxygen–glucose deprivation and reperfusion |
| IS | Ischemic stroke |
| COPD | Chronic obstructive pulmonary disease |
| hMAO-B | Human monoamine oxidase B |
| STAT3 | Transducer and activator of transcription 3 |
| CDK4 | Cyclin-dependent kinase 4 |